tiprankstipranks

New Portfolio - New Portfolio

dya

New Portfolio
Individual Investor
Ranked #72,606 out of 747,696 TipRanks' Investors
Success Rate
48%
360 out of 755
profitable transactions
Average Return
47.06%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 4.40%
6-Month Return▲ 13.23%
12-Month Return▲ 11.44%
YTD Return▲ 13.06%
Total Return▲ 170.89%

Best Trade

Opened at
Closed at-
Gain▲ 4535.65%

Bio

Primarily growth stocks for long term commitment; some sector leaders that I may rotate in or out.

Performance

29.87%0-29.87%
▲ 5.14%
▲ 4.57%
▲ 9.51%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 0.21%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 4.69%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 1.18%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 4.09%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 6.06%
May 2024
▼ 2.25%
▲ 3.53%
▲ 1.49%
Jun 2024
▲ 29.87%
▲ 0.88%
▲ 3.16%
Jul 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 5.14%▲ 4.57%▲ 9.51%
▼ 1.87%▲ 1.59%▲ 0.21%
▲ 14.08%▲ 5.22%▲ 4.69%
▲ 5.05%▲ 3.27%▲ 1.18%
▼ 12.40%▼ 4.03%▼ 4.09%
▲ 11.46%▲ 5.06%▲ 6.06%
▼ 2.25%▲ 3.53%▲ 1.49%
▲ 29.87%▲ 0.88%▲ 3.16%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Rhythm Pharmaceuticals
0.25%
▲ 35.55%
9
Sell
Jul 16, 2024
Iovance Biotherapeutics
0.22%
▼ 20.64%
3
Buy
Jul 16, 2024
Repare Therapeutics
0.15%
▲ 10.18%
2
Buy
Jul 16, 2024
Arcutis Biotherapeutics
0.24%
▲ 26.67%
3
Sell
Jul 16, 2024
Cellectar Biosciences
▼ 28.92%
3
Close
Jun 27, 2024
Springworks Therapeutics
0.27%
▲ 0.14%
2
Buy
Jun 27, 2024
Delcath Systems
0.28%
▲ 81.09%
4
Sell
Jun 24, 2024
Perspective Therapeutics
▲ 607.91%
4
Close
Jun 17, 2024
Blueprint Medicines
▲ 34.64%
5
Close
Jun 06, 2024
Shockwave Medical
▲ 697.02%
3
Close
May 30, 2024
TransMedics Group
▲ 565.20%
9
Close
May 20, 2024
Urogen Pharma
0.33%
▲ 14.18%
3
Buy
May 13, 2024
Deciphera Pharmaceuticals
▲ 107.04%
5
Close
May 08, 2024
Ultragenyx Pharmaceutical
0.49%
▲ 5.49%
6
Buy
May 07, 2024
Okta
▼ 60.85%
4
Close
Apr 24, 2024
Travere Therapeutics
▼ 28.29%
3
Close
Apr 22, 2024
iShares 20+ Year Treasury Bond ETF
▲ 2.66%
2
Close
Apr 15, 2024
Xeris Pharmaceuticals
▼ 28.36%
4
Close
Apr 12, 2024
Rocket Pharmaceuticals
0.17%
▼ 14.46%
5
Buy
Apr 11, 2024
Ascendis Pharma
0.12%
▲ 22.13%
4
Sell
Apr 10, 2024